These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Hydroxychloroquine: A Brief Review on Screening, Toxicity, and Progression. Modi YS; Singh RP; Fine HF Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):207-17. PubMed ID: 26985794 [No Abstract] [Full Text] [Related]
49. Chemotherapy of onchocerciasis: a controlled clinical trial of topical diethylcarbamazine (DEC) in Guatemala. Taylor HR; Langham ME; de Stahl EM; Figueroa LN; Beltranena F Tropenmed Parasitol; 1980 Sep; 31(3):357-64. PubMed ID: 7003855 [TBL] [Abstract][Full Text] [Related]
50. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects. Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074 [TBL] [Abstract][Full Text] [Related]
51. The Clonidine side effect in the human eye. Turacli ME Ann Ophthalmol; 1974 Jul; 6(7):699-709. PubMed ID: 4843885 [No Abstract] [Full Text] [Related]
52. [The therapeutic difficulties of ocular onchocerciasis]. Toufic N Arch Ophtalmol Rev Gen Ophtalmol; 1969 Nov; 29(11):777-84. PubMed ID: 4243964 [No Abstract] [Full Text] [Related]
53. Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis. Turner PF; Rockett KA; Ottesen EA; Francis H; Awadzi K; Clark IA J Infect Dis; 1994 May; 169(5):1071-5. PubMed ID: 8169393 [TBL] [Abstract][Full Text] [Related]
54. Visual function loss from vigabatrin: effect of stopping the drug. Johnson MA; Krauss GL; Miller NR; Medura M; Paul SR Neurology; 2000 Jul; 55(1):40-5. PubMed ID: 10891902 [TBL] [Abstract][Full Text] [Related]
55. The chemotherapy of onchocerciasis II. Quantitation of the clinical reaction to microfilaricides. Awadzi K Ann Trop Med Parasitol; 1980 Apr; 74(2):189-97. PubMed ID: 7002073 [TBL] [Abstract][Full Text] [Related]
57. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Diallo S; Aziz MA; Lariviere M; Diallo JS; Diop-Mar I; N'Dir O; Badiane S; Py D; Schulz-Key H; Gaxotte P Trans R Soc Trop Med Hyg; 1986; 80(6):927-34. PubMed ID: 3299905 [TBL] [Abstract][Full Text] [Related]
58. [Short review of pathophysiology and therapeutic possibilities in onchocerciasis with reference to a case report]. Winkler S; Wenisch C; Wiesinger E; Breyer S; Graninger W Wien Klin Wochenschr; 1994; 106(11):354-8. PubMed ID: 8053203 [TBL] [Abstract][Full Text] [Related]
59. Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery. Jones BR; Anderson J; Fuglsang H Br J Ophthalmol; 1978 Jul; 62(7):428-39. PubMed ID: 678494 [TBL] [Abstract][Full Text] [Related]
60. [Triamcinolone in the prevention of secondary reactions to hetrazan]. Berhard JA; Figueroa LN; García Manzo GA Salud Publica Mex; 1964; 6(5):835-41. PubMed ID: 5889350 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]